• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN

Last Price$421.45Day Change (%)4.29%
Open Price$405.12Day Change ($)17.33
Day Range402.37–421.9552-Week Range329.09–592.59

As of Tue 9/27/2016 5:15:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Global Rectal Cancer Therapeutics Pipeline Review 2016 - 7 Companies & 9 Molecules - Research and Markets

    Global Rectal Cancer Therapeutics Pipeline Review 2016 - 7 Companies & 9 Molecules - Research and Markets

  2. Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

    Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, With Asthma and Cystic Fibrosis Leading the Way - Research and Markets

  3. T-Cell Redirecting Bispecific Antibodies Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Adimab, Affimed Therapeutics, Alligator Biosciences - Research and Markets

    T-Cell Redirecting Bispecific Antibodies Report 2016 - Analysis, Technologies & Forecasts - Key Vendors: Adimab, Affimed Therapeutics, Alligator Biosciences - Research and Markets

  4. Sanofi, Regeneron Announce Positive Trials for Cholesterol Drug

    Sanofi, Regeneron Announce Positive Trials for Cholesterol Drug

  5. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  6. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  7. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  8. Aberdeen to Buy Artio Global Investors

    As part of Aberdeen's acquisition of Artio, some international fund managers to depart. Also, a management change on a T. Rowe Price health-care fund, Columbia hires Putnam's former asset-allocation head, and ClearBridge and Legg Mason Capital Management funds to merge.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.